BALMF News Alert Balmoral Resources (BALMF) 1.4221 09/19/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Balmoral Resources (BALMF) 1.4221 $BALMF

Xmet Receives Drill Permits for Its 100% Owned Grasset Property, the Eastern Extension of Balmoral Resources' Grasset
Marketwire - Tue Sep 16, 8:05AM CDT
Xmet Inc. ("Xmet" or the "Corporation" (TSX VENTURE: XME) is pleased to announce that it has received its work and drill permit for its Grasset Property from the Province of Quebec's Ministry of Natural Resources.

Balmoral to Be Added to S&P/TSX Small Cap Index
Marketwire - Mon Sep 15, 6:30AM CDT
Balmoral Resources Ltd. ("Balmoral" or the "Company" (TSX: BAR) (OTCQX: BALMF) is pleased to announce that as at the close of trading on Friday, September 19, 2014 Balmoral will be added to the S&P/TSX SmallCap Index.

Midland Options Its Samson Ni-Cu-PGE and Gold Property to Donner Metals Near Balmoral's Discovery on Grasset
Marketwire - Mon Sep 08, 7:04AM CDT
Midland Exploration Inc. ("Midland" (TSX VENTURE: MD) is pleased to announce the execution of a new option agreement with Donner Metals Ltd. ("Donner" for its Samson property, currently wholly owned by Midland and which consists of 512 claims covering a surface area of about 284 square kilometres about 50 kilometres west of the town of Matagami, in Abitibi, Quebec. This new property has a strong potential for nickel, copper, Platinum Group Elements ("Ni-Cu-PGE" and gold and is located about 5 kilometres south of the recent Ni-Cu-PGE and gold discoveries made by Balmoral Resources Ltd ("Balmoral" on the Grasset project. Recently, Balmoral announced the discovery of a high-grade Ni-Cu-PGE zone, with values up to 1.79% Ni, 0.19% Cu, 0.42 g/t Pt, and 1.04 g/t Pd over 45.28 metres including an interval grading 10.6% Ni, 0.45% Cu, 2.04 g/t Pt, and 5.23 g/t Pd over 1.10 metre and 1.62% Ni, 0.18% Cu, 0.36 g/t Pt and 0.88 g/t Pd over 54.08 metres (see press releases by Balmoral dated May 20, 2014 and August 18, 2014).

Balmoral Provides Exploration Update
Marketwire - Thu Sep 04, 6:31AM CDT
Balmoral Resources Ltd. ("Balmoral" or the "Company" (TSX: BAR) (OTCQX: BALMF) today provided an update on exploration activities on its Detour Gold Trend Project in Quebec. Drilling continues on the Project with two drills. Results from 40 holes remain pending and are anticipated over the next several weeks.

GTA to Form Joint Venture to Advance the Northshore Property
Marketwire - Mon Aug 18, 6:31AM CDT
GTA Resources and Mining Inc. (TSX VENTURE: GTA) announces that it has advised Balmoral Resources Inc. ("Balmoral" that GTA will not exercise its second option under the Northshore Property Option Agreement. As a result GTA and Balmoral will now form a participatory joint venture to further explore and develop the Northshore Property in Ontario. GTA will hold an initial 51% interest in the joint venture and be the initial joint venture operator.

Balmoral Intersects 54.08 Metres Grading 1.62% Ni, 0.18% Cu, 0.36 g/t Pt and 0.88 g/t Pd at Grasset
Marketwire - Mon Aug 18, 6:30AM CDT
Balmoral Resources Ltd.(TSX: BAR) (OTCQX: BALMF)

Balmoral Commences Airborne Geophysical Survey of Grasset Nickel Trend, Detour Project, Quebec
Marketwire - Wed Aug 06, 6:32AM CDT
Balmoral Resources Ltd. (TSX: BAR) (OTCQX: BALMF) ("Balmoral" or the "Company" announced today that it has commenced a low-level, high-resolution, airborne electromagnetic ("EM" survey, which will target additional occurrences of nickel-copper-PGE mineralization within the Grasset Ultramafic Complex ("GUC" . The southern end of the GUC hosts Balmoral's high-grade Grasset nickel-copper-PGE discovery. The GUC trends northwest for over 16 kilometres from the discovery area and this will be the first modern low-level airborne survey over the bulk of the GUC.

Balmoral Completes Acquisition of 100% Ownership of Entirety of Grasset Ultramafic Complex
Marketwire - Thu Jul 31, 6:33AM CDT
Balmoral Resources Ltd. ("Balmoral" or the "Company" (TSX: BAR) (OTCQX: BALMF) reported today that it has completed three property acquisition agreements which secure 100% ownership of the remaining 2.3 kilometres of projected strike extent of the Grasset Ultramafic Complex ("GUC" not previously held by the Company. The GUC hosts the Company's high-grade Grasset Nickel-Copper-PGE discovery 13.5 kilometres to the south of the properties acquired. As a result of today's acquisitions, Balmoral controls a 100% interest in a 23 kilometre long northwest-trending belt underlain by strongly magnetic rocks marking the Grasset Ultramafic Complex and potential extensions. In addition to nickel-copper-PGE mineralization the belt has confirmed potential for both gold and zinc-copper (VMS) discoveries.

GTA Updates Progress on its Ontario Projects and Announces a Flow-Through Private Placement
Marketwire - Wed Jul 16, 7:03AM CDT
GTA Resources and Mining Inc. (TSX VENTURE: GTA) provides an update on its projects in Northern Ontario and outlines exploration plans for the second half of 2014. To supplement its present treasury of approximately $1.2 million, GTA also announces its intent to raise up to $500,000 in flow-through funds by completing a non-brokered private placement. The use of proceeds will be to carry out field work on GTA's three northern Ontario properties.

Balmoral Receives First Option Vesting Notice From GTA on Northshore Property, Ontario
Marketwire - Wed Jul 16, 6:30AM CDT
Balmoral Resources Ltd. ("Balmoral" or the "Company" (TSX: BAR) (OTCQX: BALMF) reported today that it has received First Option Vesting Notice under the Northshore Property Agreement ( the "Agreement"; see NR11-17; July 27, 2011) from GTA Resources and Mining Inc. ("GTA" (TSX VENTURE: GTA). Under the terms of the Agreement GTA, who have been the operator on the property since 2011, have the right under the First Option to earn a 51% interest in the Northshore Property from Balmoral subject to making a series of cash and share payments and completing $2,500,000 in expenditures on the Property. Balmoral has received the required cash and share payments and is currently reviewing the expenditure statement provided by GTA which, if accepted, will trigger formal vesting of GTA's First Option Interest in the Property. The Company anticipates it will complete its review within the next 10-12 days.

Balmoral Resumes Drilling of Martiniere Gold System, Detour Gold Trend Project, Quebec
Marketwire - Tue Jul 08, 6:30AM CDT
Balmoral Resources Ltd. (TSX: BAR) (OTCQX: BALMF) ("Balmoral" or the "Company" announced today that drilling has resumed on the Company's wholly owned Martiniere Gold Project located along the Detour Gold Trend in Central Quebec. Drilling at Martiniere will initially focus on further testing of the southern segment of the Bug Lake Gold Zone following the success of the winter 2014 drill program in this area. This will be followed by further testing/infill drilling of the northern segment of the Bug Lake Zone which returned numerous strong intercepts including 1,138 g/t gold over 4.38 metres in the most recently completed phase of drilling (see NR14-10; May 12, 2014).




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading